Robert T. Eagan
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
- Metastasis and carcinoma case studies
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Diagnosis and Treatment 39
- Lung Cancer Treatments and Mutations 18
- Brain Metastases and Treatment 5
- Oncology 34
- Lung Cancer Research Studies 26
- Cancer Treatment and Pharmacology 5
- Co-authors
- Stephen Frytak (47 shared papers)Peter C. Pairolero (5 shared papers)James N. Ingle (23 shared papers)Clifton F. Mountain (2 shared papers)Lucius D. Hill (2 shared papers)Robert J. Ginsberg (2 shared papers)Thomas R. Fleming (11 shared papers)Edward T. Creagan (25 shared papers)
- Journals
- Cancer (9 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Mayo Clinic Proceedings (4 papers)Journal of Clinical Oncology (4 papers)Oncology (3 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Robert T. Eagan
99 papers receiving 2.6k citations
Robert T. Eagan's Hit Papers
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 1.8k
- Oncology 761
- Genetics 130
- Toxicology 51
- Cancer Research 123
Countries citing papers authored by Robert T. Eagan
This map shows the geographic impact of Robert T. Eagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Eagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Eagan more than expected).
Fields of papers citing papers by Robert T. Eagan
This network shows the impact of papers produced by Robert T. Eagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Eagan. The network helps show where Robert T. Eagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert T. Eagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Modern thirty-day operative mortality for surgical resections in lung cancer Hit paper breakdown → | 1983 | 542 |
| 2 | 1984 | 227 | |
| 3 | 1974 | 109 | |
| 4 | 1979 | 97 | |
| 5 | 1984 | 85 | |
| 6 | Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer. | 1977 | 84 |
| 7 | 1994 | 82 | |
| 8 | 1989 | 80 | |
| 9 | Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer. | 1987 | 71 |
| 10 | 1984 | 64 | |
| 11 | 1983 | 62 | |
| 12 | 1973 | 53 | |
| 13 | Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer. | 1975 | 52 |
| 14 | cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung. | 1978 | 51 |
| 15 | A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer. | 1981 | 51 |
| 16 | 1994 | 48 | |
| 17 | 1987 | 46 | |
| 18 | VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer. | 1976 | 44 |
| 19 | VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung. | 1978 | 44 |
| 20 | 1984 | 43 |
About Robert T. Eagan
Robert T. Eagan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Toxicology and Cancer Research, having authored 102 papers that have together received 3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (39 papers), Lung Cancer Research Studies (26 papers), Lung Cancer Treatments and Mutations (18 papers), Cancer therapeutics and mechanisms (9 papers), Glioma Diagnosis and Treatment (9 papers), Bioactive Compounds and Antitumor Agents (7 papers), Cancer Treatment and Pharmacology (5 papers) and Brain Metastases and Treatment (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.8k citations), Oncology (761 citations), Genetics (130 citations), Toxicology (51 citations) and Cancer Research (123 citations). Robert T. Eagan has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Stephen Frytak, Peter C. Pairolero, James N. Ingle, Clifton F. Mountain, Lucius D. Hill, Robert J. Ginsberg, Thomas R. Fleming, Edward T. Creagan, L. Herbert Maurer and R. Jackson Forcier. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics, Mayo Clinic Proceedings, Journal of Clinical Oncology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.